Safety and efficacy of intracoronary recombinant human prourokinase administration in patients with acute myocardial infarction and ST‑segment elevation: A meta‑analysis of randomized controlled trials

Slow blood flow or no reflow following percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) typically leads to an adverse prognosis. However, it is controversial whether to use prourokinase (Pro-UK) during PCI in patients with acute STEMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Gang, Wu, Xiang-Ge, Jiao, Wen-Ping, Zhang, Hong-Kao, Guo, Dian-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764045/
https://www.ncbi.nlm.nih.gov/pubmed/36569445
http://dx.doi.org/10.3892/etm.2022.11739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764045/
https://www.ncbi.nlm.nih.gov/pubmed/36569445
http://dx.doi.org/10.3892/etm.2022.11739

Ejemplares similares